Skip navigation and go to main content
05 September 2016: co.don Share: WARBURG RESEARCH GmbH confirms buy recommendation and target price for co.don share - for more information please click the marquee text
+ Technology leader in cartilage transplantation increases revenue by some 20% year on year
See how to use the therapy with cartilage cells from patients' own cells and blood for your patients. Over 10,000 successful procedures demonstrate our competence. more »
Your own cells constitute the best raw material for growing tissue that can be used for the lasting reconstruction of cartilage and vertebral defects. more »
Why not find out about our company's rapid development and ambitious targets? As a shareholder you too will benefit from the positive long-term performance of our market capitalisation. more »
Warthestr. 21D-14513 TeltowT:+49(0)3328 43460F:+49(0)3328434643info[at]codon.de
Copyright © 2016 co.don® AG.